Therefore, our results suggest that pharmacological inhibition of sEH ameliorates most of the characteristic features of NPC mice, demonstrating that sEH can be considered a potential therapeutic target for this disease. This evidence concerns the gene EPHX2 and nasopharyngeal carcinoma.